Company Overview

Development Stage

About the Company

[Summary] A biopharmaceutical company dedicated to the research, development, pr

Kangfang Pharmaceutical Co., Ltd., with a company size of fewer than 50 employees and a company type of foreign-funded (European and American), is engaged in the pharmaceutical and bioengineering industry.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (116 open positions)

Manage
Note: How fast is hiring at Kangfang Pharmaceutical Co., Ltd. growing? 2025: 76 openings (down 11%), 2024: 85 openings (up 21%), 2023: 70 openings (up 438%), 2022: 13 openings (down 91%), 2021: 137 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Kangfang Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2026: 24 openings (up 124%), 2024: 3 openings (up 21%), 2023: 2 openings (up 438%), 2021: 3 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Kangfang Pharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2026: 2 openings (up 124%), 2024: 1 openings (up 21%), 2023: 1 openings (up 438%).

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Kangfang Pharmaceutical Co., Ltd.? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 31.7%, "其他(研发和技术类)": 15.1%, "计算机/网络/技术类": 11.8%, "医疗卫生/美容保健类": 9.1%, "机械/仪器仪表类": 7%, "电子/电器/通信技术类": 2.2%. For reference only.

— What Are the Salaries Like? (186 records)

Manage
salary range: 4.5K - 50K, 60.2% of roles pay ¥8-15K
Note: salary statistics are based on 186 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Kangfang Pharmaceutical Co., Ltd.?60.2% of positions earn 8-15K, Fresh graduate salary: ¥7.0K。工厂生产类 average salary ¥9.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Kangfang Pharmaceutical Co., Ltd.? We provide: 分析,qc,研究助理,qa,生产技术,开发工程师,hr,仓库,库管,物料管理,临床,工艺助理,系统开发,高级专员,bp,采购,保安,合规,精密仪器,系统管理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 工厂生产类
    34.3% of total 34.3%
  • 生物/制药/化工/环保类
    32.4% of total 32.4%
  • 质量管理类
    28% of total 28%
  • 经营管理类
    15.9% of total 15.9%

Education

  • 本科
    63.8% of total 63.8%
  • 大专
    15.5% of total 15.5%
  • 硕士
    11.6% of total 11.6%
  • 不限
    6.3% of total 6.3%

Experience

  • 不限
    70% of total 70%
  • 3-5年
    11.6% of total 11.6%
  • 1-3年
    8.7% of total 8.7%
  • 5-10年
    8.7% of total 8.7%
View Detailed Analysis

What does Kangfang Pharmaceutical Co., Ltd. require? Who is Kangfang Pharmaceutical Co., Ltd. hiring? recruitment: 工厂生产类占比最多占34.3%,其次是生物/制药/化工/环保类占32.4%. What education can get in at ? 本科占比最多占63.8%,其次是大专占15.5%. High education required at ? 硕士占11.6%,博士占1%. Work experience required at ? 不限占比最多占70%,其次是3-5年占11.6%. Where are the job locations at ? 广州占比最多占85%,其次是中山占7.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 20,000万(元)
Legal Representative: XIA YU
Date Established:
Credit Code: 91440101MA59RLWX21
Registered Address: 广州市黄埔区康耀南路158号

Partners & Suppliers

澎立生物为康方生物提供临床前安全性评价服务 Source
供应商 制药企业
2022年12月,康方生物与默沙东就AK112(PD-1/VEGF双抗)达成全球独家授权协议,默沙东获得除中国以外的全球权益,并支付首付款和里程碑付款。 Source
合作客户 技术授权/合作开发
药明生物为康方生物提供抗体药物生产服务,包括细胞系开发、工艺开发及大规模生产。 Source
供应商 CDMO/CMO
康方生物与正大天晴成立合资公司,共同开发PD-1单抗派安普利单抗(AK105),康方生物提供技术,正大天晴负责生产和销售,康方生物获得授权收入和销售分成。 Source
合作客户 技术授权/合作开发
为其派安普利单抗、卡度尼利单抗提供中心实验室服务 Source
供应商 制药企业

People who follow this company also follow

Competitors (Similar Companies)

“Dedicated to the research, development, production, and commercializat”
“is a modern, international, Sino-foreign joint venture pharmaceutical ”
制药/药业 医药 生物制药 医药工业
“A well-known multinational company in the global ophthalmic optics and”
维生素 医药 大健康 药妆
生物制品 生物医药 生物制药 疫苗
制药/药业 医药 中医药 医药分析
“A modern comprehensive pharmaceutical enterprise integrating R&D, prod”
“Committed to becoming an innovative leader in the field of molecular t”
制药/药业 创新药 抗感染药物 新药研发
股权投资 投融资 国企改革 产业投资
制药/药业 医药 生物制药 原料药
制药/药业 生物制品 抗生素 中成药
医药 药物研发 大健康 药材种植
制药/药业 医药 维生素 葡萄糖

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates